Germline BRCA-mutated HER2-negative Breast Cancer
1 clinical trials · Condition
◉ Watch Germline BRCA-mutated HER2-negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study (NCT05576389) | Peking University People's Hospital | 2022-10-01 |
Track Germline BRCA-mutated HER2-negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.